| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.4 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |